Determination of protein binding of gyrase inhibitors by means of continuous ultrafiltration

Journal of Pharmaceutical and Biomedical Analysis

Volumn 18, Issue 4-5, 1998, Pages 847-858

  Zlotos, G ^a   Oehlmann, M ^b   Nickel, P ^b   Holzgrabe, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NONE   (Germany)

Author keywords

Continuous ultrafiltration; Gyrase inhibitors; Protein binding

Indexed keywords

BOVINE SERUM ALBUMIN; CINOXACIN; CIPROFLOXACIN; DIFLOXACIN; ENOXACIN; ENROFLOXACIN; FLEROXACIN; GREPAFLOXACIN; GYRASE INHIBITOR; HUMAN SERUM ALBUMIN; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OXOLINIC ACID; PEFLOXACIN; PIPEMIDIC ACID; RUFLOXACIN; SPARFLOXACIN; TROVAFLOXACIN;

ARTICLE; HUMAN; IN VITRO STUDY; NONHUMAN; PLASMA; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; ULTRAFILTRATION;

ANIMALS; BLOOD PROTEINS; CATTLE; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; HUMANS; MODELS, CHEMICAL; PROTEIN BINDING; ULTRAFILTRATION;

EID: 0032447578     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00220-9     Document Type: Article

References (31)

1. L.Z. Benet, D.L. Kroetz, L.B. Sheiner, in: J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A. Goodman Gilman (Eds.), Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1996, pp. 3-27.
2. J. Oravcova, B. Bohs, W. Lindner, J. Chromatogr. B 677 (1996) 1-28.
3. D.S. Campion, R. Olsen, J. Pharm. Sci. 63 (1974) 249-252.
4. A. Kinawi, C. Teller, Arzneim. Forsch. 29 (1979) 1495-1499.
5. P. Nickel, R. Schlerf, Pharm. Ztg. 128 (1983) 1234-1238.
6. M. Oehimann, P. Nickel, Pharm. i. u. Z. 25 (1996) 202.
7. J. Jürgens, H. Schedletzky, P. Heisig, J.K. Seydel, B. Wiedemann, U. Holzgrabe, Arch. Pharm. Pharm. Med. Chem. 329 (1996) 179-190.
8. G. Zlotos, A. Bücker, M. Kinzig-Schippers, F. Sörgel, U. Holzgrabe, J. Pharm. Sci. 87 (1998) 215-220.
9. A. Kinawi, Arch. Pharm. (Weinheim) 323 (1990) 523-524.
10. H. Illy, Dissertation, Bonn, 1991.
11. M. Oehimann, Dissertation, Bonn, 1996.
12. A. Albert, E.P. Serjeant, The determination of ionisation constants, Methuen, London, 1971.
13. R. Olsen, D.D. Christ, Ann. Rep. Med. Chem. 31 (1996) 327-336.
14. T. Izumi, T. Kitagawa, Chem. Pharm. Bull. 37 (1989) 742-745.
15. E. Okezaki, T. Terasaki, M. Nakamura, O. Nagata, H. Kato, A. Tsuji, J. Pharm. Sci. 78 (1989) 504-507.
16. H. Jarboe, B. R. Toth, K.E. Shoemaker, K.J. Greenlees, K.M. Kleinow, Xenobiotica 23 (1993) 961-972.
17. F. Sörgel, M. Kinzig, Am. J. Med. 94 (1994) 56-69.
18. W. Cullmann, A.M. Geddes, E. Wiedekamm, H. Urwyler, A. Braunsteiner, Int. J. Antimicrob. Agents 2 (1993) 203-230.
19. C.H. Nightingale, Am. J. Med. 94 (1994) 38-43.
20. G. Montay, Y. Goueffon, F. Roquet, Antimicrob. Agents Chemother. 25 (1984) 463-472.
21. N. Manek, J.M. Andrews, R. Wise, Antimicrob. Agents Chemother. 30 (1986) 330-332.
22. E. Brunt, J. Limberg, H. Derendorf, J. Pharm. Biomed. Anal. 8 (1990) 67-71.
23. R. Wise, J.M. Andrews, L.J. Edwards, Antimicrob. Agents Chemother. 23 (1983) 559-564.
24. B. Joos, B. Ledergerber, M. Flepp, J.-D. Bettex, R. Luthy, W.J. Siegenthaler, Antimicrob. Agents Chemother. 27 (1985) 353-356.
25. L. Kaartinen, M. Salonen, L. Alli, S. Pyorala, J. Vet. Pharmacol. Ther. 18 (1995) 357-362.
26. A. Dalhoff, Pharmacokinetics of Selected Antibacterial Agents in Antibiotics and Chemotherapy, Karger, Basel, vol. 49, 1998, p. 85.
27. M.A. Cooper, J.M. Andrews, J.P. Ashby, R.S. Matthews, R. Wise, J. Antimicrob. Chemother. 26 (1990) 667-676.
28. Arzneimittelinformationen, Pharm. Ztg. 18 (1987) 1098.
29. R. Davis, H.M. Bryson, Drugs 47 (1994) 677-700.
30. R. Wise, J.M. Andrews, R.S. Matthews, M. Wolstenholme, J. Antimicrob. Chemother. 29 (1992) 649-660.
31. Brochure of Pfizer GmbH.